London, June 01, 2020 (GLOBE NEWSWIRE) -- According to a new market research report “COVID-19 (Coronavirus) Impact Assessment: Health and Life Sciences (Coronavirus, Epidemiology, Economic Impact), Product Pipeline (Diagnosis (PCR Testing, Antibody testing), Treatment (Immunotherapy, Vaccines, Antiviral, Cell-based, Plasma therapy), and Geography”, published by Meticulous Research®, the antibodies, protein-based vaccines, anti-viral, cell-based therapies are expected to lead the COVID-19 treatment pipeline.
Download Free Sample Report Now @ https://www.meticulousresearch.com/download-sample-report/cp_id=5098
The high transmission rate of coronavirus that lead to rapid increase in COVID-19 cases and deaths world-wide, triggered the rapid growth in diagnostic and treatment needs. However, lack of information on the novel virus such as biological, genetic information, duration of immunity granted in recovered patients, among others, which is vital to develop a safe & effective treatment option, has been a key challenge in achieving a successful solution.
With the growing cases of COVID-19 and its impact on the healthcare industry, this report analyses the diagnosis and treatments areas widely. The diagnosis segment is further divided into PCR-based testing and antibody testing; whereas, the treatment area is segmented into vaccines, immunotherapies, anti-virals, cell-based therapies, and other therapies. Vaccines and anti-virals are the most explored treatment options currently being investigated by researchers worldwide. The study also evaluates product pipeline based on development stage.
COVID-19 crisis has affected various countries differently based on traveller volumes, responsiveness of government to the infections, and capabilities of healthcare systems, among other factors. Geographically, North America has been the most affected region, primarily attributed to the U.S. being the most affected country having most number of confirmed cases as well as deaths, globally (as of 25th May 2020). Other most affected nations include the U.K., Spain, France, Italy, Brazil, and Germany among others. Further, almost all the affected nations have experienced rapid economic decline leading GDP decline, increase in unemployment rates, and increase in inflation rates.
Speak to our Analysts to Understand the Impact of COVID-19 on Your Business: https://www.meticulousresearch.com/download-sample-report/cp_id=5098
The governments across the globe are implementing actions to overcome the situation. Primary focus has been restriction on people movement, setting up emergency screens and treatment centres, creating mass awareness, and accelerating research and development for COVID-19. For instance, in the U.S., the Biomedical Advanced Research and Development Authority (BARDA), a federal agency that funds disease-fighting technology, has stated an investment of nearly USD 1 billion to support coronavirus vaccine development. Similarly, the U.K.’s National Health Services (NHS) announced GBP 24.6 million funding as a part of rapid research responses.
Some of the key players engaged in the COVID-19 diagnosis and treatment development include Roche Holding AG (Switzerland), Thermo Fisher Scientific, Inc. (U.S.), Abbott Laboratories (U.S.), Becton, Dickinson and Company (U.S.), AbbVie Corporation (U.S.), Gilead Sciences, Inc. (U.S.), Eli Lilly and Company (U.S.), Moderna, Inc. (U.S.), Novavax, Inc. (U.S.), Medicago, Inc. (U.S.), Inovio Pharmaceuticals, Inc. (U.S.), GlaxoSmithKline (U.K.), Sanofi S.A. (France), Johnson & Johnson (U.S.), Sorrento Therapeutics, Inc. (U.S.), AstraZeneca Plc (U.K.), Pfizer, Inc. (U.S.), CTI Biopharma Corporation (U.S.), OncoImmune, Inc. (U.S.), Athersys, Inc. (U.S.), Celularity, Inc. (U.S.), Pluristem Therapeutics (Israel), and Takeda Pharmaceuticals Company Ltd (Japan), among others.
Click here to get the short-term and long-term impact of COVID-19 on this Market.
Please visit: https://www.meticulousresearch.com/product/COVID-19-impact-assessment-health-and-life-sciences-industry-5098/
Scope of the Report:
COVID-19 Product Pipeline
- Diagnosis
- PCR Testing
- Antibody Testing
- Treatment
- Vaccines
- Immunotherapy
- Antiviral
- Cell-based Therapy
- Other Therapies
COVID-19: Impact on Healthcare Industry
- Diagnostics
- Rapid Test Kits
- PCR / Rapid Antigen Testing / Nucleic Acid-Based Tests
- Advantages Offered by PCR Testing in COVID -19 Diagnosis
- Restraints
- Key Companies
- Antibody Testing / Serological Testing
- Advantages Over Molecular Tests
- Use of Antibody Testing for Herd Immunity Analysis and Easing Lock-Down
- Restraints
- Key Companies
- Therapies
- Vaccines
- Immunotherapies (Antibodies)
- Monoclonal Antibody
- T-Cell Therapy
- Potential Game Changers: Antibodies
- Ilaris (Canakinumab)
- Sylvant (Siltuximab)
- Lenzilumab
- Ultomiris (Ravulizumab-Cwvz)
- Tocilizumab
- Anti-Virals
- Potential Game Changers
- Chloroquine and Hydroxychloroquine (HCQ)
- Remdesivir
- Cell-Based Therapies
- Other Therapies
- Plasma Therapy
- Devices
- Potential Game Changers
COVID-19 Industry Impact Assessment, by Geography
- North America
- Europe
- Asia-Pacific (APAC)
- Rest of the World (RoW)
Download Free Sample Report Now @ https://www.meticulousresearch.com/download-sample-report/cp_id=5098
Amidst this crisis, Meticulous Research® is continuously assessing the impact of COVID-19 pandemic on various sub-markets and enables global organizations to strategize for the post-COVID-19 world and sustain their growth. Let us know if you would like to. assess the impact of COVID-19 on any industry here- https://www.meticulousresearch.com/custom-research.php
Related Reports:
Infectious Disease Diagnostics Market by Product and Solution (Consumables, System, Software and Services), Technology (Immunodiagnostics, PCR, INAAT), Disease (HIV, HAIS, Influenza), End User (Hospital, Reference Lab, Research) - Global Forecast to 2027
Vaccines Market by Indication (Influenza, Rotavirus, DTP Vaccines), Route of Administration (Intramuscular, Subcutaneous, Oral), Type/Antigen (Conjugate Vaccine, Live Attenuated Vaccine), Valence (Multivalent, Monovalent Vaccines) - Global Forecast to 2027
Ventilators Market by Product (Instruments, Accessories), Mobility (Intensive Care, Portable), Interface (Invasive, Non-invasive), Age Group (Adult, Pediatric), Mode (Volume, Pressure, Dual), End User (Hospital, ASCs, Home Care) – Global Forecast to 2027
Point of Care Molecular Diagnostics Market by Product and Solution (Assay, Analyzer, Software, Services), Technology (RT-qPCR, INAAT), Application (Respiratory Diseases, Hospital Acquired Infections, STD), and End User - Global Forecast to 2027
Medical/Hospital Beds Market by Product (Bed, Accessories), Technology (Power, Manual), Type of Care (Curative, Rehabilitation), Healthcare Facilities (Critical, Bariatric, Long-term, Paediatric, Maternal, Home Care) - Global Forecast to 2027
About Meticulous Research®
The name of our company defines our services, strengths, and values. Since the inception, we have only thrived to research, analyze and present the critical market data with great attention to details.
Meticulous Research® was founded in 2010 and incorporated as Meticulous Market Research Pvt. Ltd. in 2013 as a private limited company under the Companies Act, 1956. Since its incorporation, with the help of its unique research methodologies, the company has become the leading provider of premium market intelligence in North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa regions.
With the meticulous primary and secondary research techniques, we have built strong capabilities in data collection, interpretation, and analysis of data including qualitative and quantitative research with the finest team of analysts. We design our meticulously analyzed intelligent and value-driven syndicate market research reports, custom studies, quick turnaround research, and consulting solutions to address business challenges of sustainable growth.